Medicines Co. (MDCO) Receives FDA Approval for New MINOCIN Formulation
Tweet Send to a Friend
Medicines Co. (NASDAQ: MDCO) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE